CAMELLIA-TIMI 61

CAMELLIA-TIMI 61 is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study in overweight and obese subjects with CV disease and/or multiple CV risk factors

LINK TO CLINICALTRIALS.GOV

TRIAL SITE LOG-IN